80 FR 61425 - Issuance of Final Guidance Publications
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 80, Issue 197 (October 13, 2015)
Centers for Disease Control and Prevention
Federal Register Volume 80, Issue 197 (October 13, 2015)
| Page Range | 61425-61425 | |
| FR Document | 2015-25974 |
[Federal Register Volume 80, Number 197 (Tuesday, October 13, 2015)] [Notices] [Page 61425] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-25974] [[Page 61425]] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [CDC-2013-0022; Docket Number NIOSH-153-B] Issuance of Final Guidance Publications AGENCY: National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of issuance of final guidance publications. ----------------------------------------------------------------------- SUMMARY: The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), announces the availability of the following 15 Skin Notation Profiles [DHHS (NIOSH) Publication Nos. 2015-191 to 2015-195 and 2015-226 to 2015-235]: Substance(s) Aldrin: http://www.cdc.gov/niosh/docs/2015-191/pdfs/f15_snp_aldrin_2015-191.pdf. Aniline: http://www.cdc.gov/niosh/docs/2015-192/pdfs/f15_snp_aniline_2015-192.pdf. Azinphos-methyl: http://www.cdc.gov/niosh/docs/2015-235/pdfs/f15_snp_2015-235.pdf. Captafol: http://www.cdc.gov/niosh/docs/2015-193/pdfs/f15_snp_captafol_2015-193.pdf. Chlordane: http://www.cdc.gov/niosh/docs/2015-229/pdfs/f15_snp_2015-229.pdf. Dieldrin: http://www.cdc.gov/niosh/docs/2015-229/pdfs/f15_snp_2015-229.pdf. Dinitro-o-cresol: http://www.cdc.gov/niosh/docs/2015-195/pdfs/f15_snp_dinitro-o-cresol_2015-195.pdf. Endrin: http://www.cdc.gov/niosh/docs/2015-233/pdfs/f15_snp_2015-233.pdf. Methyl parathion: http://www.cdc.gov/niosh/docs/2015-231/pdfs/f15_snp_2015-231.pdf. Nicotine: http://www.cdc.gov/niosh/docs/2015-234/pdfs/f15_snp_2015-234.pdf. Parathion: http://www.cdc.gov/niosh/docs/2015-232/pdfs/f15_snp_2015-232.pdf. Phorate: http://www.cdc.gov/niosh/docs/2015-230/pdfs/f15_snp_2015-230.pdf. Phosdrin: http://www.cdc.gov/niosh/docs/2015-226/pdfs/f15_snp_2015-226.pdf. Tetraethyl dithionopyrophosphate (TEDP): http://www.cdc.gov/niosh/docs/2015-227/pdfs/f15_snp_2015-227.pdf. Tetraethyl pyrophosphate (TEPP): http://www.cdc.gov/niosh/docs/2015-228/pdfs/f15_snp_2015-228.pdf. ADDRESSES: These documents may be obtained at the following link: http://www.cdc.gov/niosh/topics/skin/skin-notation_profiles.html. FOR FURTHER INFORMATION CONTACT: Naomi Hudson, NIOSH, Robert A. Taft Laboratories, 1090 Tusculum Avenue, MS C-32, Cincinnati, OH 45226. (513) 533-8388 (not a toll free number). Email: [email protected]. Dated: October 5, 2015. John Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 2015-25974 Filed 10-9-15; 8:45 am] BILLING CODE 4163-19-P
![Federal Register / Vol. 80, No. 197 / Tuesday, October 13, 2015 / Notices 61425
DEPARTMENT OF HEALTH AND Dieldrin: http://www.cdc.gov/niosh/ DEPARTMENT OF HEALTH AND
HUMAN SERVICES docs/2015-229/pdfs/f15_snp_2015- HUMAN SERVICES
229.pdf.
Centers for Disease Control and Dinitro-o-cresol: http://www.cdc.gov/ Administration for Children and
Prevention niosh/docs/2015-195/pdfs/f15_snp_ Families
dinitro-o-cresol_2015-195.pdf.
[CDC–2013–0022; Docket Number NIOSH– Endrin: http://www.cdc.gov/niosh/docs/ Submission for OMB Review;
153–B] 2015-233/pdfs/f15_snp_2015-233.pdf. Comment Request
Methyl parathion: http://www.cdc.gov/
Issuance of Final Guidance niosh/docs/2015-231/pdfs/f15_snp_ Title: Title IV–E Plan for Foster Care,
Publications 2015-231.pdf. Adoption Assistance, and, optional,
Nicotine: http://www.cdc.gov/niosh/ Guardianship Assistance Programs.
AGENCY: National Institute for docs/2015-234/pdfs/f15_snp_2015-
Occupational Safety and Health 234.pdf. OMB No.: 0970–0433.
(NIOSH) of the Centers for Disease Parathion: http://www.cdc.gov/niosh/ Description: A title IV–E plan is
Control and Prevention (CDC), docs/2015-232/pdfs/f15_snp_2015- required by section 471, part IV–E of the
Department of Health and Human 232.pdf. Social Security Act (the Act) for each
Services (HHS). Phorate: http://www.cdc.gov/niosh/ public child welfare agency requesting
ACTION: Notice of issuance of final docs/2015-230/pdfs/f15_snp_2015- Federal funding for foster care, adoption
guidance publications. 230.pdf. assistance and guardianship assistance
Phosdrin: http://www.cdc.gov/niosh/ under the Act. Section 479B of the Act
SUMMARY: The National Institute for docs/2015-226/pdfs/f15_snp_2015-
provides for an Indian tribe, tribal
Occupational Safety and Health 226.pdf.
Tetraethyl dithionopyrophosphate organization or tribal consortium (Tribe)
(NIOSH) of the Centers for Disease to operate a title IV–E program in the
Control and Prevention (CDC), (TEDP): http://www.cdc.gov/niosh/
docs/2015-227/pdfs/f15_snp_2015- same manner as a State with minimal
announces the availability of the exceptions. The Tribe must have an
following 15 Skin Notation Profiles 227.pdf.
Tetraethyl pyrophosphate (TEPP): approved title IV–E Plan. The title IV–
[DHHS (NIOSH) Publication Nos. 2015– E plan provides assurances the
http://www.cdc.gov/niosh/docs/2015-
191 to 2015–195 and 2015–226 to 2015– programs will be administered in
228/pdfs/f15_snp_2015-228.pdf.
235]:
ADDRESSES: These documents may be conformity with the specific
Substance(s) obtained at the following link: http:// requirements stipulated in title IV–E.
Aldrin: http://www.cdc.gov/niosh/docs/ www.cdc.gov/niosh/topics/skin/skin- The plan must include all applicable
2015-191/pdfs/f15_snp_aldrin_2015- notation_profiles.html. State or Tribal statutory, regulatory, or
191.pdf. FOR FURTHER INFORMATION CONTACT: policy references and citations for each
Aniline: http://www.cdc.gov/niosh/ Naomi Hudson, NIOSH, Robert A. Taft requirement as well as supporting
docs/2015-192/pdfs/f15_snp_aniline_ Laboratories, 1090 Tusculum Avenue, documentation. A title IV–E agency may
2015-192.pdf. MS C–32, Cincinnati, OH 45226. (513) use the pre-print format prepared by the
Azinphos-methyl: http://www.cdc.gov/ 533–8388 (not a toll free number). Children’s Bureau of the Administration
niosh/docs/2015-235/pdfs/f15_snp_ Email: iuz8@cdc.gov. for Children and Families or a different
2015-235.pdf. Dated: October 5, 2015. format, on the condition that the format
Captafol: http://www.cdc.gov/niosh/ John Howard, used includes all of the title IV–E plan
docs/2015-193/pdfs/f15_snp_ Director, National Institute for Occupational
requirements of the law.
captafol_2015-193.pdf. Safety and Health, Centers for Disease Control Respondents: Title IV–E agencies
Chlordane: http://www.cdc.gov/niosh/ and Prevention. administering or supervising the
docs/2015-229/pdfs/f15_snp_2015- [FR Doc. 2015–25974 Filed 10–9–15; 8:45 am] administration of the title IV–E
229.pdf. BILLING CODE 4163–19–P programs.
ANNUAL BURDEN ESTIMATES
Number of Average
Number of Total burden
Instrument responses per burden hours
respondents hours
respondent per response
Title IV–E Plan ................................................................................................. 17 1 16 272
Estimated Total Annual Burden of the information collection. Email recommendations for the proposed
Hours: 272. address: infocollection@acf.hhs.gov. information collection should be sent
Additional Information OMB Comment directly to the following: Office of
Management and Budget, Paperwork
mstockstill on DSK4VPTVN1PROD with NOTICES
Copies of the proposed collection may OMB is required to make a decision Reduction Project, Email: OIRA_
be obtained by writing to the concerning the collection of information SUBMISSION@OMB.EOP.GOV. Attn:
Administration for Children and between 30 and 60 days after
Families, Office of Planning, Research publication of this document in the
and Evaluation, 370 L’Enfant Federal Register. Therefore, a comment
Promenade SW., Washington, DC 20447, is best assured of having its full effect
Attn: ACF Reports Clearance Officer. All if OMB receives it within 30 days of
requests should be identified by the title publication. Written comments and
VerDate Sep<11>2014 21:23 Oct 09, 2015 Jkt 238001 PO 00000 Frm 00092 Fmt 4703 Sfmt 4703 E:\FR\FM\13OCN1.SGM 13OCN1](https://thefederalregister.org/doc/80_FR_61622/page/1.svg)
Document Created: 2018-02-27 08:47:40
Document Modified: 2018-02-27 08:47:40
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of issuance of final guidance publications. | |
| Contact | Naomi Hudson, NIOSH, Robert A. Taft Laboratories, 1090 Tusculum Avenue, MS C-32, Cincinnati, OH 45226. (513) 533-8388 (not a toll free number). Email: [email protected] | |
| FR Citation | 80 FR 61425 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR